Keserű GM - Search Results

1

Exploring protein hotspots by optimized fragment pharmacophores.

Bajusz D, Wade WS, Satała G, Bojarski AJ, Ilaš J, Ebner J, Grebien F, Papp H, Jakab F, Douangamath A, Fearon D, von Delft F, Schuller M, Ahel I, Wakefield A, Vajda S, Gerencsér J, Pallai P, Keserű GM. Bajusz D, et al. Among authors: keseru gm. Nat Commun. 2021 May 27;12(1):3201. doi: 10.1038/s41467-021-23443-y. Nat Commun. 2021. PMID: 34045440 Free PMC article.

2

Fragment-based lead discovery on G-protein-coupled receptors.

Visegrády A, Keserű GM. Visegrády A, et al. Among authors: keseru gm. Expert Opin Drug Discov. 2013 Jul;8(7):811-20. doi: 10.1517/17460441.2013.794135. Epub 2013 Apr 29. Expert Opin Drug Discov. 2013. PMID: 23621346 Review.

3

Virtual fragment screening on GPCRs: a case study on dopamine D3 and histamine H4 receptors.

Vass M, Schmidt É, Horti F, Keserű GM. Vass M, et al. Among authors: keseru gm. Eur J Med Chem. 2014 Apr 22;77:38-46. doi: 10.1016/j.ejmech.2014.02.034. Epub 2014 Feb 15. Eur J Med Chem. 2014. PMID: 24607587 Free article.

4

Discovery of Subtype Selective Janus Kinase (JAK) Inhibitors by Structure-Based Virtual Screening.

Bajusz D, Ferenczy GG, Keserű GM. Bajusz D, et al. Among authors: keseru gm. J Chem Inf Model. 2016 Jan 25;56(1):234-47. doi: 10.1021/acs.jcim.5b00634. Epub 2015 Dec 31. J Chem Inf Model. 2016. PMID: 26682735

5

Ensemble docking-based virtual screening yields novel spirocyclic JAK1 inhibitors.

Bajusz D, Ferenczy GG, Keserű GM. Bajusz D, et al. Among authors: keseru gm. J Mol Graph Model. 2016 Nov;70:275-283. doi: 10.1016/j.jmgm.2016.10.014. Epub 2016 Oct 17. J Mol Graph Model. 2016. PMID: 27771575

6

Identification of 8-Hydroxyquinoline Derivatives Active Against Somatic V658F Mutant JAK1-Dependent Cells.

Kiss R, Bajusz D, Baskin R, Tóth K, Monostory K, Sayeski PP, Keserű GM. Kiss R, et al. Among authors: keseru gm. Arch Pharm (Weinheim). 2016 Dec;349(12):925-933. doi: 10.1002/ardp.201600246. Epub 2016 Nov 10. Arch Pharm (Weinheim). 2016. PMID: 27862215

7

Binding thermodynamics discriminates fragments from druglike compounds: a thermodynamic description of fragment-based drug discovery.

Williams G, Ferenczy GG, Ulander J, Keserű GM. Williams G, et al. Among authors: keseru gm. Drug Discov Today. 2017 Apr;22(4):681-689. doi: 10.1016/j.drudis.2016.11.019. Epub 2016 Dec 1. Drug Discov Today. 2017. PMID: 27916639 Review.

8

Structure-based Virtual Screening Approaches in Kinase-directed Drug Discovery.

Bajusz D, Ferenczy GG, Keseru GM. Bajusz D, et al. Among authors: keseru gm. Curr Top Med Chem. 2017;17(20):2235-2259. doi: 10.2174/1568026617666170224121313. Curr Top Med Chem. 2017. PMID: 28240180 Review.

9

Spiro[pyrrolidine-3,3'-oxindoles] and Their Indoline Analogues as New 5-HT6 Receptor Chemotypes.

Kelemen ÁA, Satala G, Bojarski AJ, Keserű GM. Kelemen ÁA, et al. Among authors: keseru gm. Molecules. 2017 Dec 14;22(12):2221. doi: 10.3390/molecules22122221. Molecules. 2017. PMID: 29240714 Free PMC article.

10

Validation of tautomeric and protomeric binding modes by free energy calculations. A case study for the structure based optimization of D-amino acid oxidase inhibitors.

Orgován Z, Ferenczy GG, Steinbrecher T, Szilágyi B, Bajusz D, Keserű GM. Orgován Z, et al. Among authors: keseru gm. J Comput Aided Mol Des. 2018 Feb;32(2):331-345. doi: 10.1007/s10822-018-0097-y. Epub 2018 Jan 15. J Comput Aided Mol Des. 2018. PMID: 29335871

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

224 results

Search Page